Autolus Therapeutics plc 2024 This fall – Outcomes – Earnings Name Presentation (NASDAQ:AUTL)
This text was written byObserveIn search of Alpha's transcripts group is chargeable for the event of all of our transcript-related ...
Wednesday, March 26, 2025
Tag: Therapeutics
Fulcrum Therapeutics, Inc. (FULC) This fall 2024 Earnings Name Transcript
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) This fall 2024 Earnings Convention Name February 25, 2025 8:00 AM ET Firm Individuals Alex Sapir ...
Stuart Therapeutics Proclaims the Appointment of Two New Board Members By Investing.com
Stuart Therapeutics provides acknowledged leaders in ophthalmology therapeutics growth, commercialization. STUART, Fla., Dec. 22, 2024 /PRNewswire/ -- Stuart Therapeutics introduced ...
Depth Therapeutics is establishing a brand new area of localized most cancers discount: CEO
Depth Therapeutics, Inc. (NASDAQ: INTS) is a scientific biotechnology firm engaged within the discovery growth, and commercialization of first-in-class most ...
Piper Sandler raises confidence in Tenaya Therapeutics inventory forward of December knowledge, reiterates Obese ranking By Investing.com
On Friday, Piper Sandler confirmed its Obese ranking on Tenaya Therapeutics Inc (NASDAQ:TNYA) with a gentle worth goal of $40.00. ...
Eliem therapeutics govt sells over $9,000 in firm inventory By Investing.com
Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) Chief Accounting Officer, Emily Pimblett, has just lately offered a portion of her firm inventory, in ...
Biora Therapeutics, Inc. (BIOR) Q2 2024 Earnings Name Transcript
Biora Therapeutics, Inc. (NASDAQ:BIOR) Q2 2024 Earnings Convention Name August 12, 2024 4:30 PM ET Firm Individuals Chuck Padala - ...
AbbVie completes acquisition of Cerevel Therapeutics
Michael Vi/iStock Editorial by way of Getty Photos AbbVie (NYSE:ABBV) has accomplished its ~$8.7B ($45 per share) acquisition of Cerevel ...
Sarepta Therapeutics’ Pullback After Current FDA Approval A Shopping for Alternative (SRPT)
JOSE LUIS CALVO MARTIN & JOSE ENRIQUE GARCIA-MAURIÑO MUZQUIZ Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is synonymous with Duchenne Muscular Dystrophy ("DMD"). ...
Crispr Therapeutics Stays Costly With Slower Casgevy Monetization And Patent Battle
Andy CRSP's Gene Modifying Expertise Has Lastly Been Accepted CRSP's Gene Modifying Expertise CRSP CRISPR Therapeutics AG (NASDAQ:CRSP) is a ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.